**Author details**

Yuji Yamada1 and Tomiki Sumiyoshi<sup>2</sup> \*

1 Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan

2 Department of Preventive Intervention for Psychiatric Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan

\*Address all correspondence to: sumiyot@ncnp.go.jp

© 2023 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

*Social Cognitive Impairments as a Target of Non-Invasive Brain Stimulation for Functional… DOI: http://dx.doi.org/10.5772/intechopen.112742*

## **References**

[1] Moreno-Küstner B, Martín C, Pastor L. Prevalence of psychotic disorders and its association with methodological issues. A systematic review and meta-analyses. PLoS One. 2018;**13**(4):e0195687

[2] Yamada Y, Inagawa T, Sueyoshi K, Sugawara N, Ueda N, Omachi Y, et al. Social cognition deficits as a target of early intervention for psychoses: A systematic review. Frontiers in Psychiatry. 2019;**10**:333

[3] Pinkham AE, Penn DL, Green MF, Buck B, Healey K, Harvey PD. The social cognition psychometric evaluation study: Results of the expert survey and RAND panel. Schizophrenia Bulletin. 2014;**40**(4):813-823

[4] Couture SM, Penn DL, Roberts DL. The functional significance of social cognition in schizophrenia: A review. Schizophrenia Bulletin. 2006;**32**(Suppl 1): S44-S63

[5] Fett AK, Viechtbauer W, Dominguez MD, Penn DL, van Os J, Krabbendam L. The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis. Neuroscience and Biobehavioral Reviews. 2011;**35**(3):573-588

[6] Sumiyoshi T, Nishida K, Niimura H, Toyomaki A, Morimoto T, Tani M, et al. Cognitive insight and functional outcome in schizophrenia; a multi-center collaborative study with the specific level of functioning scale-Japanese version. Schizophraphy Research Cognition. 2016;**6**:9-14

[7] Yamada Y, Okubo R, Tachimori H, Uchino T, Kubota R, Okano H, et al.

Pharmacological interventions for social cognitive impairments in schizophrenia: A protocol for a systematic review and network meta-analysis. Frontiers in Psychology. 2022;**13**:878829

[8] Bürkner PC, Williams DR, Simmons TC, Woolley JD. Intranasal oxytocin may improve high-level social cognition in schizophrenia, but not social cognition or Neurocognition in general: A multilevel Bayesian Meta-analysis. Schizophrenia Bulletin. 2017;**43**(6):1291-1303

[9] Gabay AS, Kempton MJ, Mehta MA. Facial affect processing deficits in schizophrenia: A meta-analysis of antipsychotic treatment effects. Journal of Psychopharmacology. 2015;**29**(2):224-229

[10] Kishi T, Ikuta T, Oya K, Matsunaga S, Matsuda Y, Iwata N. Anti-dementia drugs for psychopathology and cognitive impairment in schizophrenia: A systematic review and Metaanalysis. The International Journal of Neuropsychopharmacology. 2018;**21**(8):748-757

[11] Yamada Y, Inagawa T, Hirabayashi N, Sumiyoshi T. Emotion recognition deficits in psychiatric disorders as a target of non-invasive Neuromodulation: A systematic review. Clinical EEG and Neuroscience. 2022;**53**(6):506-512

[12] Yamada Y, Sumiyoshi T. Neurobiological mechanisms of transcranial direct current stimulation for psychiatric disorders; neurophysiological, chemical, and anatomical considerations. Frontiers in Human Neuroscience. 2021;**15**:631838

[13] Yamada Y, Sumiyoshi T. Preclinical evidence for the mechanisms

of transcranial direct current stimulation in the treatment of psychiatric disorders: A systematic review. Clinical EEG Neuroscience. 2021;**13**:15500594211066151

[14] Walther S, Kunz M, Müller M, Zürcher C, Vladimirova I, Bachofner H, et al. Single session transcranial magnetic stimulation ameliorates hand gesture deficits in schizophrenia. Schizophrenia Bulletin. 2020;**46**(2):286-293

[15] Wölwer W, Lowe A, Brinkmeyer J, Streit M, Habakuck M, Agelink MW, et al. Repetitive transcranial magnetic stimulation (rTMS) improves facial affect recognition in schizophrenia. Brain Stimulation. 2014;**7**(4):559-563

[16] Rassovsky Y, Dunn W, Wynn J, Wu AD, Iacoboni M, Hellemann G, et al. The effect of transcranial direct current stimulation on social cognition in schizophrenia: A preliminary study. Schizophrenia Research. 2015;**165**(2-3):171-174

[17] Rassovsky Y, Dunn W, Wynn JK, Wu AD, Iacoboni M, Hellemann G, et al. Single transcranial direct current stimulation in schizophrenia: Randomized, crossover study of neurocognition, social cognition, ERPs, and side effects. PLoS One. 2018;**13**(5):e0197023

[18] Yamada Y, Inagawa T, Yokoi Y, Shirama A, Sueyoshi K, Wada A, et al. Efficacy and safety of multi-session transcranial direct current stimulation on social cognition in schizophrenia: A study protocol for an open-label, singlearm trial. Journal of Persian Medicine. 2021;**11**(4):317

[19] Yamada Y, Sumiyoshi T. Transcranial direct current stimulation and social cognition impairments of Schizophrenia; current knowledge and future

Perspectives. Horizons in Neuroscience Research. 2022;**46**. New York: Nova Science Publishers:143-170

[20] Yamada Y, Matsumoto M, Iijima K, Sumiyoshi T. Specificity and continuity of schizophrenia and bipolar disorder: Relation to biomarkers. Current Pharmaceutical Design. 2020;**26**(2):191-200

[21] Yamada Y, Sueyoshi K, Yokoi Y, Inagawa T, Hirabayashi N, Oi H, et al. Transcranial direct current stimulation on the left superior temporal sulcus improves social cognition in schizophrenia: An open-label study. Frontiers in Psychiatry. 2022;**13**:862814

## **Chapter 4**
